☆ 4.2 Article

COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People

MEDICINA-LITHUANIA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Medicine, General & Internal

Who wants his dose?

[Anonymous]

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination

Constantin Schwab et al.

Summary: This study describes autopsy findings of myocarditis in individuals who died unexpectedly after receiving anti-SARS-CoV-2 vaccination. Acute myocarditis was identified in four patients who received mRNA vaccination, with no other significant diseases or health issues detected. Histological examination revealed T-lymphocytic infiltration in the myocardium, predominantly involving the CD4 positive subset, and mild myocyte damage. Overall, the findings indicate that myocarditis can be a potentially lethal complication following mRNA-based anti-SARS-CoV-2 vaccination, and can help to diagnose unclear cases and establish timely in vivo diagnosis for monitoring and treating severe clinical cases.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States

Diego Montano

Summary: This study provides a risk assessment of adverse reactions related to COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer-BioNTech. The results show a higher risk of serious adverse reactions for COVID-19 vaccines compared to influenza vaccines, particularly among individuals aged 65 and older.

FRONTIERS IN PUBLIC HEALTH (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Frailty and COVID-19 mRNA Vaccine Antibody Response in the COVID-19 Community Research Partnership

Charles T. Semelka et al.

Summary: Frailty is associated with impaired antibody response to COVID-19 mRNA vaccines in adults aged 55 and older. Frail individuals are less likely to seroconvert and more likely to serorevert compared to nonfrail individuals.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2022)

添加到收藏夹

Letter Medicine, General & Internal

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

Gili Regev-Yochay et al.

Summary: Health care workers in Israel received a fourth dose of mRNA vaccine during the prevalence of the omicron variant. The fourth dose boosted antibody levels but did not surpass the maximum observed after the third dose. The vaccine demonstrated an efficacy of 31 to 43% against symptomatic disease.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Review Geriatrics & Gerontology

NF-κB, a culprit of both inflamm-ageing and declining immunity?

Preeyaporn Songkiatisak et al.

Summary: NF-kappa B is an important regulator of ageing, playing roles in cellular senescence and inflammatory pathways. It affects the immune system and is related to inflamm-ageing and declining adaptive immunity. It also functions in other areas beyond the immune system. However, the complexity of NF-kappa B has not received much attention in ageing research.

IMMUNITY & AGEING (2022)

添加到收藏夹

Article Medicine, General & Internal

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France

Jeremie Botton et al.

Summary: This study assessed the short-term risk for severe cardiovascular events after COVID-19 vaccination in adults younger than 75 years in France. The study found that adenoviral-based vaccines may be associated with an increased incidence of myocardial infarction and pulmonary embolism, while mRNA-based vaccines showed no association with the cardiovascular events studied.

ANNALS OF INTERNAL MEDICINE (2022)

添加到收藏夹

Article Immunology

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults

Joseph Fraiman et al.

Summary: This study found that mRNA COVID-19 vaccines are associated with an excess risk of serious adverse events, emphasizing the need for formal harm-benefit analyses, particularly those stratified according to risk of serious COVID-19 outcomes.

VACCINE (2022)

添加到收藏夹

Article Health Care Sciences & Services

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial

Ai -Min Hui et al.

Summary: BNT162b2 vaccination demonstrated strong immune response with acceptable tolerability in Han Chinese adults. However, the follow-up duration was relatively short and COVID-19 rates were not assessed. Safety data collection is ongoing until 12 months after the second dose.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)

添加到收藏夹

Review Medicine, General & Internal

Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic

Jannis Kountouras et al.

Summary: The COVID-19 pandemic requires a comprehensive approach to guide healthcare policies and balance physical and mental health. Achieving widespread immunity is the priority, and preventing transmission relies on non-pharmacological measures. Treatment options after infection vary in terms of benefits and adverse events.

MEDICINA-LITHUANIA (2022)

添加到收藏夹

News Item Medicine, General & Internal

Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination

Ingrid Torjesen

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Geriatrics & Gerontology

Association of frailty with outcomes in individuals with COVID-19: A living review and meta-analysis

Flavia Dumitrascu et al.

Summary: Frailty is significantly associated with adverse outcomes in COVID-19 patients, including increased mortality risk and higher rates of delirium. Frailty assessment is important for guiding prognosis and personalized care planning, but more data on patient-reported outcomes related to frailty status are urgently needed.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

Xintong Li et al.

Summary: This study highlights significant variations in the background incidence rates of 15 prespecified adverse events associated with covid-19 vaccines across different databases. Certain adverse events increase with age, while others are more prevalent in younger individuals. Meta-analytic estimates of adverse event rates have been classified by age and sex.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Review Medicine, General & Internal

Does COVID-19 Vaccination Warrant the Classical Principle ofelein i mi vlaptin?

Michael Doulberis et al.

Summary: The article underscores the urgent issues in the development of COVID-19 vaccines, including the risks of rapid vaccine development and the effectiveness of vaccines against new variants. It calls for scientists and clinicians to pay attention to these issues for more comprehensive management.

MEDICINA-LITHUANIA (2021)

添加到收藏夹

Article Immunology

Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019

Zijie Shen et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Oncology

RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of BRCA1-Null Cancers

John J. Krais et al.

CANCER RESEARCH (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes

Massimiliano Bonafe et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Tao Zuo et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Geriatrics & Gerontology

Association of frailty with mortality in older inpatients with Covid-19: a cohort study

Darren Aw et al.

AGE AND AGEING (2020)

添加到收藏夹

Article Immunology

Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza

Silan Gu et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Letter Infectious Diseases

The lung tissue microbiota features of 20 deceased patients with COVID-19

Jun Fan et al.

JOURNAL OF INFECTION (2020)

添加到收藏夹

Review Virology

Immunological co-ordination between gut and lungs in SARS-CoV-2 infection

Shruti Ahlawat et al.

VIRUS RESEARCH (2020)

添加到收藏夹

Review Immunology

Vaccination in the elderly: The challenge of immune changes with aging

Annalisa Ciabattini et al.

SEMINARS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Immunology

Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults

Xu Yao et al.

VACCINE (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.